ReviewDermatologie (Heidelberg, Germany)2025
[Onychomycosis in children and adolescents-case report and overview of the literature].
Review in Dermatologie (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungal nail infections in children and adolescents are on the rise worldwide. Diagnosis and, above all, treatment is a challenge. A 15-year-old girl had been suffering from onychomycosis of the toenails for more than 6 years, and later also of a fingernail on her right hand. Trichophyton (T.) rubrum had already been identified by culture and polymerase chain reaction (PCR) as the pathogen years ago. However, treatment attempts with topical antimycotics and fluconazole did not lead to a cure. Mycological diagnostics using PCR and sequencing of the ITS (Internal Transcribed Spacer) region of the rDNA of the dermatophyte confirmed the diagnosis of tinea unguium caused by T. rubrum. Ciclopiroxolamine-containing water-soluble nail varnish and oral terbinafine were used for treatment, both in off-label use and with the consent of the girl's parents. Terbinafine was given continuously once daily and subsequently intermittently once weekly. After 7 months of combined antifungal therapy, the nail mycosis of the fingernails and toenails healed completely. The endpoint of the therapy was clinical healing and negative PCR for T. rubrum. There have been no recurrences over the past more than 3 years-first under prophylaxis with the antifungal nail varnish.
Indexed as
Identifiers
40205226What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.